Sales rise 91.70% to Rs 72.02 crore
Net profit of Marksans Pharma reported to Rs 16.79 crore in the quarter ended June 2013 as against net loss of Rs 19.73 crore during the previous quarter ended June 2012. Sales rose 91.70% to Rs 72.02 crore in the quarter ended June 2013 as against Rs 37.57 crore during the previous quarter ended June 2012. ParticularsQuarter EndedJun. 2013Jun. 2012% Var.Sales72.0237.57 92 OPM %30.01-40.32 -PBDT19.41-17.58 LP PBT17.21-19.73 LP NP16.79-19.73 LPPowered by Capital Market - Live News
